Hefei Hengxin Life Science and Technology Co., Ltd. (SHE:301501)
China flag China · Delayed Price · Currency is CNY
40.36
+0.30 (0.75%)
At close: Mar 9, 2026

SHE:301501 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Debt / Equity Ratio
0.100.370.270.270.070.10
Upgrade
Debt / EBITDA Ratio
0.581.230.790.770.270.56
Upgrade
Debt / FCF Ratio
---67.383.63-
Upgrade
Net Debt / Equity Ratio
-0.250.100.02-0.14-0.20-0.17
Upgrade
Net Debt / EBITDA Ratio
-1.600.350.05-0.41-0.75-0.99
Upgrade
Net Debt / FCF Ratio
5.25-1.41-0.14-35.61-9.942.30
Upgrade
Asset Turnover
-0.901.021.121.140.81
Upgrade
Inventory Turnover
-5.614.994.663.993.01
Upgrade
Quick Ratio
1.830.680.790.891.051.06
Upgrade
Current Ratio
2.411.031.321.401.881.97
Upgrade
Return on Equity (ROE)
-22.71%28.96%29.39%19.21%7.44%
Upgrade
Return on Assets (ROA)
-8.96%11.43%12.09%10.42%5.13%
Upgrade
Return on Invested Capital (ROIC)
14.37%20.85%30.09%34.63%26.56%11.98%
Upgrade
Return on Capital Employed (ROCE)
11.30%19.70%23.50%23.80%19.50%11.10%
Upgrade
Payout Ratio
25.31%5.19%3.57%11.96%12.14%105.74%
Upgrade
Buyback Yield / Dilution
-19.59%-0.31%0.04%-5.81%--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.